Ideas & Insights

Amid the COVID-19 pandemic, life sciences companies, thrust in the spotlight, are positioned for strong growth.

Applications to sell unused state net operating losses and state research and development credits available the week of May 1, 2020.

Learn about opportunities for life sciences foreign direct investment (FDI) into the United States with this complimentary webcast.

An update on the economic impacts, kbusiness continuity strategies, and considerations from an audit, tax, VAT and supply chain perspective.

RSM professionals explain the parties involved and information needed for life sciences companies to comply with the federal law.

Here are some ways coronavirus could leave its mark on the global VAT, trade and tariff landscape for the life sciences industry.

The AICPA released the SOC for Supply Chain report to aid organizations with relevant controls to address business risk.

Corporate taxpayers filing a consolidated return have an added layer of rules to navigate when carrying back a net operating loss.

Life sciences companies: Learn the importance of anticipating and managing key risks when working with third parties in our helpful e-book.

The IRS provided long-awaited guidance for taxpayers anxious to take advantage of the NOL provisions in the CARES Act.

Recent guidance provides that certain deadlines, including the allowable time to invest in a QOF, are now extended because of COVID-19.

The IRS issued guidance extending the time for taxpayers to file certain Form 3115s and Form 1128s to July 15, 2020.

As businesses renegotiate debts in the aftermath of COVID-19, it is critical to understand whether the debt is considered publicly traded.

Accelerating worthless stock deductions on an insolvent subsidiary without disposing of the business to increase NOL carrybacks.

Delaware notices advise companies to either participate in the state’s unclaimed property VDA Program or be subject to an audit.

Proper evaluation can help life sciences companies prevent the undue state tax exposures when launching a new drug.

Emerging technology and life sciences companies can apply for a refundable tax credit for their qualifying investments.

Get yourself up to speed on the latest trends in private equity and M&A with the 2019 annual HC and LS Industry Spotlight.

Department issued compliance alert explains the sales and use tax collection responsibilities for marketplace facilitators and sellers.

Three states have prescriptions for opioid taxes on manufacturers and distributors. Here’s what you need to know.